PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31656041-10	2020	An interaction between PPIs and CYP2C19 metaboliser status on exposure to specific ATV analytes (e.g. interaction p=0.0071 for 2-OH ATV L) was observed.	atorvastatin	83-86	cytochrome P450 family 2 subfamily C member 19	Homo sapiens	32-39	
31897532-9	2020	In the atorvastatin group, CYP2C19*2, CYP3A4*1G, and ABCB1 C3435T TT genotypes were independent determinants of PRU values (P < 0.01).	atorvastatin	7-19	cytochrome P450 family 2 subfamily C member 19	Homo sapiens	27-34	
31897532-10	2020	CONCLUSION: The CYP2C19*2 allele is the primary determinant of the exposition to the H4 active metabolite of clopidogrel and platelet reactivity in patients co-treated with atorvastatin or rosuvastatin.	atorvastatin	173-185	cytochrome P450 family 2 subfamily C member 19	Homo sapiens	16-23	
31656041-10	2020	An interaction between PPIs and CYP2C19 metaboliser status on exposure to specific ATV analytes (e.g. interaction p=0.0071 for 2-OH ATV L) was observed.	atorvastatin	132-135	cytochrome P450 family 2 subfamily C member 19	Homo sapiens	32-39